ACEA Biosciences Overview

  • Founded
  • 2002
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 201
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $250M
Latest Deal Amount

ACEA Biosciences General Information

Description

Developer of cell analysis instruments designed to help in life science research and clinical diagnostics. The company's instruments use microelectrodes in automated high-throughput plate formats to offer real time cell analysis, enabling doctors to monitor cell proliferation, cell size, cell-substrate attachment quality and cell invasion easily.

Contact Information

Website
www.aceabio.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Other Devices and Supplies
Other Industries
Biotechnology
Other Healthcare Technology Systems
Parent Company
Agilent Technologies
Primary Office
  • 6779 Mesa Ridge Road
  • Suite 100
  • San Diego, CA 92121
  • United States
+1 (858) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ACEA Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 14-Nov-2018 $250M 000.00 00000 Completed Generating Revenue
6. Later Stage VC (Series E) 01-Apr-2016 0000 000.00 00000 Completed Generating Revenue
5. Grant 03-Jul-2013 000.00 Completed Generating Revenue
4. Later Stage VC (Series D) 10-Sep-2007 00.00 000.00 000.00 Completed Generating Revenue
3. Later Stage VC (Series C) 00.000 00.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series B) $1.85M $4.15M 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) $2.3M $2.3M 00.000 Completed Generating Revenue
To view ACEA Biosciences’s complete valuation and funding history, request access »

ACEA Biosciences Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series E 0,000,000 00.000000 00 000.00 000.00 00 000.00 00.000
Series D 0,000,000 00.000000 00 00.0 00.0 00 00.0 0.000
Series C 0,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
Series B 1,589,690 $0.001000 4% $1.16 $1.16 1x $1.16 7.98%
Series A 3,199,414 $0.001000 4% $0.95 $0.95 1x $0.95 16.06%
To view ACEA Biosciences’s complete cap table history, request access »

ACEA Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of cell analysis instruments designed to help in life science research and clinical diagnostics. The company's
Other Devices and Supplies
San Diego, CA
201 As of 2016
000.00
0000 0000-00-00
000000&0 000.00

0000000

oluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non pr
00000 0000000000 0000000000 0000000
San Jose, CA
000 As of 0000
0000
000000&0 0000

000000 0

dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore ma
0000000000000
Munich, Germany
000 As of 0000
000000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ACEA Biosciences Competitors (34)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Labcyte Formerly VC-backed San Jose, CA 000 0000 000000&0 0000
000000 00000000000 Accelerator/Incubator Backed Munich, Germany 000 000000000000
000 0000000000 Venture Capital-Backed Fremont, CA 00.000 00000000000 00.000
000000 00000000 Venture Capital-Backed Cambridge, United Kingdom 00 000.00 000000000 000.00
000000000 0000 Venture Capital-Backed Pleasanton, CA 000 00000 000000000 00 00000
You’re viewing 5 of 34 competitors. Get the full list »

ACEA Biosciences Executive Team (10)

Name Title Board Seat Contact Info
Xiao Xu MD Co-Founder, Chief Executive Officer & Chairman
Xiaobo Wang Chief Technology Officer & President
Lin Jixun Co-Founder & Co-Chairman
Gang Pan Marketing Manager
Yama Abassi Ph.D Vice President
You’re viewing 5 of 10 executive team members. Get the full list »

ACEA Biosciences Board Members (3)

Name Representing Role Since
Lin Jixun ACEA Biosciences Co-Founder & Co-Chairman 000 0000
Xiao Xu MD ACEA Biosciences Co-Founder, Chief Executive Officer & Chairman 000 0000
To view ACEA Biosciences’s complete board members history, request access »

ACEA Biosciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ACEA Biosciences Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Lilly Asia Ventures Venture Capital Minority 000 0000 000000 0
Qiming Venture Partners Venture Capital Minority 000 0000 000000 0
U.S. Environmental Protection Agency Government 000 0000 000000 0
To view ACEA Biosciences’s complete investors history, request access »

Ready to get started?

Request a free trial